You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

Biogen advances Alzheimer's drug to late-stage trial despite disappointing data ○

found 2026 › May › 14 (Thu) @ 17:07 UTC

Biogen said signals sugget the treatment decreases levels of tau and slows cognitive decline, particularly at the lowest dose.